Article

Non-mydriatic retinal camera receives 510(k) clearance

The FDA has given 510(k) clearance to a non-mydriatic retinal camera (CR-2, Canon U.S.A.).

Lake Success, NY-The FDA has given 510(k) clearance to a non-mydriatic retinal camera (CR-2, Canon U.S.A.).

The camera’s 33-pound weight eases installation and transportation when needed, according to the company. The control panel is illuminated to enable medical staff to navigate operations in darkened rooms. The camera’s white LED lamp uses less power than a xenon tube and lasts about twice as long, which can help to reduce energy costs in medical facilities.

“Obtaining FDA clearance . . . helps reaffirm our commitment to eye-care professionals by instituting superb imaging technology and, in turn, contributing to the quality care of their patients,” said Tsuneo Imai, senior director and general manager, medical systems division, Canon U.S.A.

The camera is available for purchase through authorized Canon dealers.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.